Nuclear translocation of dihydrofolate reductase is not a pre-requisite for DNA damage induced apoptosis

Ting-Ting Yuan,Ying Huang,Ci-Xiang Zhou,Yun Yu,Li-Shun Wang,Han-Yi Zhuang,Guo-Qiang Chen
DOI: https://doi.org/10.1007/s10495-009-0343-9
2009-01-01
APOPTOSIS
Abstract:Dihydrofolate reductase (DHFR) is a key enzyme for the synthesis of thymidylate, and therefore, of DNA. By applying subcellular proteomic analysis, we identified that the DHFR protein was translocated from cytoplasm into the nucleus when apoptosis was induced by NSC606985, a camptothecin analogue. The nuclear translocation of DHFR protein during apoptosis was independent of the cellular context, but it was more sensitive in cell death induction by DNA damaging agents such as doxorubicin, etoposide and ultraviolent radiation than endoplasmic reticulum stressors (brefeldin-A and tunicamycin) and anti-microtubule agents (paclitaxel and nocodozole). The addition of methotrexate almost completely blocked the nuclear translocation of DHFR protein. Further investigations showed that the nuclear translocation of DHFR was not a pre-requisite for DNA damage induced apoptosis. Therefore, its potential biological significance remains to be further explored.
What problem does this paper attempt to address?